Cargando…
Fitness of use of Biopatch® and Tegaderm(TM) CHG for protecting central venous catheters and arterial lines in critically ill patients
Autores principales: | Eggimann, P, Joseph, C, Thévenin, M-J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474738/ http://dx.doi.org/10.1186/2047-2994-4-S1-O26 |
Ejemplares similares
-
Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients
por: Thokala, Praveen, et al.
Publicado: (2016) -
Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance
por: Jenks, Michelle, et al.
Publicado: (2015) -
Central venous catheter-related infection in critically ill patients
por: Lorente, L, et al.
Publicado: (2004) -
Central Venous Catheter-Related Infection in Critically Ill Patients
por: dos Santos, Vitorino M., et al.
Publicado: (2019) -
Strategies to deploy interventions for prevention of infection related to central venous catheter
por: Binelli, CA, et al.
Publicado: (2011)